Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Join Barchart Premier and get daily trading ideas and historical data downloads. FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Tuhura Biosciences Inc (HURA)

Tuhura Biosciences Inc (HURA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Profile for [[ item.sessionDateDisplayLong ]]

Company Info

Tuhura Biosciences Inc 10500 UNIVERSITY CENTER DR. SUITE 110 TAMPA FL 33612 USA

https://tuhurabio.com Employees: 19 P: 813-875-6600

Sector:

Medical

INDUSTRY GROUPING:

Medical - Biomedical

Description:

TuHURA Biosciences Inc. is a Phase 3 registration-stage immuno-oncology company developing novel technologies to overcome resistance to cancer immunotherapy. The company's lead personalized cancer vaccine candidate, IFx-2.0, is designed to overcome primary resistance to checkpoint inhibitors. TuHURA Biosciences Inc., formerly known as Kintara Therapeutics Inc., is based in SAN DIEGO.

Key Statistics

Overview:

Market Capitalization, $K 38,633
Enterprise Value, $K 26,253
Shares Outstanding, K 51,258
Annual Sales, $ 0 K
Annual Net Income, $ -21,680 K
Last Quarter Sales, $ 0 K
Last Quarter Net Income, $ -7,100 K
EBIT, $ -28,530 K
EBITDA, $ -27,130 K
60-Month Beta 0.03
% of Insider Shareholders 0.20%
% of Institutional Shareholders 0.62%
Float, K 51,155
% Float 99.80%
Short Interest 3,071
Short Float 5.99%
Short Volume Ratio 0.77

Growth:

1-Year Return -81.93%
3-Year Return -99.70%
5-Year Return -99.97%
5-Year Revenue Growth 0.00%
5-Year Earnings Growth 99.98%
5-Year Dividend Growth 0.00%

Per-Share Information:

Most Recent Earnings -0.14 on 11/14/25
Next Earnings Date 01/01/70
Earnings Per Share ttm -0.50
EPS Growth vs. Prev Qtr 33.33%
EPS Growth vs. Prev Year 89.78%
Annual Dividend & Yield 0.00 (0.00%)
Annual Dividend & Yield (Fwd) 0.00 (0.00%)
Dividend Payout Ratio 0.00%
Most Recent Split 1-35 on 10/18/24

HURA Ratios

Ratio
Price/Earnings ttm 0.00
Price/Earnings forward N/A
Price/Earnings to Growth N/A
Return-on-Equity % -196.68%
Return-on-Assets % -123.41%
Profit Margin % 0.00%
Debt/Equity 0.00
Price/Sales N/A
Price/Cash Flow N/A
Price/Book 2.34
Book Value/Share 0.33
Interest Coverage -4.24
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.
Free Barchart Webinar